# Vera Therapeutics, Inc.: Form 8-K, filed Jun 2, 2026

- Company: [Vera Therapeutics, Inc.](/companies/vera.md) (CIK 1831828)
- Form: 8-K
- Filed: 2026-06-02
- Accepted by EDGAR: Jun 2, 2026, 07:05 ET
- Period: 2026-06-02
- Accession: 0001193125-26-252475
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1831828/000119312526252475/vera-20260602.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1831828/000119312526252475/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1831828/000119312526252475/vera-20260602.htm

Filed Jun 2, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-252475. Last ingested by Listed: Nov 10, 2026, 17:35 ET. No prices; not investment advice.
